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Abstract
Objective: Transfer from pediatric care into the adult
health care system is known to be a vulnerable phase in
the lives of youth with special health care needs (YSHCN).
Recommendations from the literature favor assessment of
transition readiness rather than simply pass over YSHCN
from pediatric to adult-centered care by the age of 18. Nev-
ertheless, no validated and disease neutral assessment
instrument in German exists to date. Hence, our aim was
to cross-culturally adapt and to pilot-test a German ver-
sion of the Transition Readiness Assessment Question-
naire (TRAQ 5.0). We wanted to provide a tool that can
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be applied broadly during the health care transition (HCT)
process of YSHCN.
Methods: The development included translating and
adaptingTRAQ5.0 toGermanandconducting apilot-study
with 172 YSHCN between the ages of 14 and 23.
Results: Cross-cultural adaptation resulted in the TRAQ-
GV-15. Exploratory factor analysis led to a 3 factor-
structure. Internal consistency for the overall score was
good with a Cronbach’s alpha of 0.82. Age, in contrast
to sex, had a significant effect on the TRAQ scoring. The
administration of the TRAQ-GV-15 was well received and
demonstrated good feasibility.
Conclusion: The TRAQ-GV-15 is an easily applicable and
clinically usable instrument for assessing transition readi-
ness in German speaking YSHCN prior to HCT.
Keywords: autonomy; health care self-management;
health care transition; health literacy; pediatric onset
chronic illness; youth.
Introduction
The transfer from pediatric care to adult care carries a
considerable health risk for youth with special health care
needs (YSHCN [1–3]. This phase is associated with missed
medical appointments [4, 5], poor health outcomes [6]
and lower overall quality of life [7, 8]. Recommendations
include structural changes in health care systems [9–11]
as well as propositions on how to support patients while
transferring [12–17]. Although various transition programs
have been introduced [18–21], no gold standard in transi-
tioning YSHCN from pediatric care to the adult centered
care has been established so far [11, 22–24]. Nevertheless,
an urgent need for enhanced success in transitioning is
evident in the field of chronic and rare diseases [25, 26].
Internationally, experts are working on the implemen-
tation of standardized transition processes at pediatric
clinics [27, 28].
Open Access.© 2019 Caroline Culen, Marion Herle, Marianne König, Sophie-Helene Hemberger, Sanja Seferagic, Carolin Talaska, Diana-Alexandra Ertl, Gudrun
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Transfer is usually scheduled at the age of 18 [29–31].
In some practices, youth remain in pediatric care until
the age of 24. Recent literature emphasizes focusing on
readiness for transition [32] rather than on chronological
age [33] and recommends to regularly assess and eval-
uate disease self-management and health literacy skills
in YSHCN by objective and validated tools [7, 34]. How-
ever, psychometrically sound and reliable instruments are
sparse [35, 36].
In follow-up of these recommendations,weperformed
a literature search, no validated disease neutral transi-
tion readiness assessment instrument was to be found
in the German language. However, we encountered an
instrument in the English language, developed in the
USA – the TRAQ 5.0 (Transition Readiness Assessment
Questionnaire) [37, 38]. The TRAQ has demonstrated good
reliability and validity [34], and we considered this tool
as adequate for our actual needs. Meanwhile, initial inter-
vention trials using the English TRAQ have been con-
ducted [39, 40]. Furthermore, several other cross-cultural
adaptations of the TRAQ have been carried out recently
[41–43]. This study is the first adaptation of the TRAQ 5.0
for German speaking YSHCN.
Materials and methods
Description of the original instrument
The TRAQ 5.0 [38] is a disease-neutral, self-administered
questionnaire assessing transition readiness in adoles-
cents and young adults (AYA) aged 12–26 years with
chronic conditions and therefore with special health care
needs. It comprises 20 items subdivided in 5 subscales
(“ManagingMedication”, “AppointmentKeeping”, “Track-
ing Health Issues”, “Talking With Providers” and “Man-
aging Daily Activities”). The response set of the English
TRAQ is derived from the TranstheoreticalModel [44]. Nev-
ertheless, the items score in a range from 1 (“No, I do not
know how”) to 5 (“Yes, I always do this when I need to”)
with a maximum total score of 100 and a minimum total
score of 20. A lower overall score indicates less transition
readiness.
Translation and cross-cultural adaptation of
the TRAQ
After approval of the authors of the TRAQ 5.0, the cross-
cultural adaptation of the questionnaire was conducted
according to recommendations from the pertinent litera-
ture [45]. Initially, two bilingual health care professionals
from the two study sites (Vienna, Austria and Freiburg,
Germany) familiar with the TRAQ 5.0 independently trans-
lated the original 20-item TRAQ 5.0 to German. Then,
two English native speakers (US American and Canadian,
fluent in German) both blinded to the TRAQ and not oth-
erwise involved in the study, independently translated it
back to English. In a third step, we discussed our back-
translated English versions with the authors of the TRAQ
5.0 via skype. Equivalents and discrepancies due to dif-
ferent health systems needed some considerations. Areas
that lacked consistency or clarity were discussed. We
looked for ways to translate English phrases and colloqui-
alisms in German. These edits were incorporated into the
German version. In the original American TRAQ 5.0 five
items (item 14 and item 15 as well as item 18, item 19 and
item 20, all three items assigned to the “managing daily
activities” scale) did not add statistically relevant informa-
tion in interpreting the TRAQ results: item 14 and item 15
showed low factor loadings, and furthermore, the “daily
activities” subscale showed a lower Cronbach’s alpha than
the other subscales. Therefore, the 5 items were omitted in
the German Version of the TRAQ.
Hence,weobtained an instrumentwith 15 itemswhere
scores fall betweenmaximum 75 andminimum 15. Finally,
we pilot-tested the questionnaire for comprehensibility in
a convenience sample of ten YSHCN aged 14–19 at the out-
patient clinic of theMedical University of Vienna. Minimal
changes led to our definite version, TRAQ-GV-15.
Survey sample
Our study population comprised AYA under medical care
at two outpatient clinics, the Department of Pediatrics and
Adolescent Medicine, Medical University of Vienna and
the Center for Pediatrics, Medical Centre – University of
Freiburg, Germany. Both clinics provide comprehensive
primary care services for a broad variety of chronic condi-
tions. The University of Freiburg is linked to a nationwide
transition program [46], but no standardized transition
readiness assessment has been implemented so far. In
both clinics care providers can extend medical treatment
of patients beyond the age of 18 if they think that a
transfer to adult care in the present state would pose a
health risk to the patients. Hence, the resulting conve-
nience sample from the two study sites consisted of 194
YSHCNaged fromminimum 14 tomaximum23 years of fol-
lowing outpatient clinics: Gastroenterology, Nephrology,
Endocrinology (Diabetes, Growth and Bones), and Pul-
monology. Exclusion criteria were severe cognitive impair-
ment or poor German language skills.
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Questionnaire administration
The questionnaire was administered to YSHCN at the two
study sites fromMarch 2017 to October 2017. The responses
to the self-administered paper-and-pencil survey were
collected during routine clinical care. Participants were
instructed to answer the items on the survey on their
own.However, a study investigator assistedwhenever sup-
port was needed. Clinical data were obtained from med-
ical records. Demographic data such as socioeconomic
and family background, first language and educational
level of the patients, were obtained by means of an addi-
tional anamnestic questionnaire. Supplementary infor-
mation related to the feasibility of the TRAQ like “help
needed”, “fill-in time” and “consulting time” were docu-
mented by the study investigators.
Statistics
We tested the TRAQ-GV-15 for reliability, construct valid-
ity, and scale-internal consistency. We applied the class
mean imputationmethod for correctedmean sums to com-
pensate for missing data. However, less than 0.5% of the
values of any given item were missing. We conducted
standard descriptive statistics for single items and overall
TRAQ-GV-15 score description including frequency distri-
bution, means, standard deviation, minimum, maximum
and median [47]. To test validity for age and sex we con-
ducted anANOVAwith Bonferroni adjustment formultiple
comparisons [48]. A p-value of <0.01 was considered as
statistically significant.
Because we eliminated five items from the original
TRAQ 5.0 therewas no evidence for a beforehand structure
of our adapted 15 items instrument. Therefore, we con-
ducted an exploratory factor analysis (EFA). We verified
adequacy of the sampling with Kaiser-Meyer-Olkin- and
Bartlett’s-Test. We conducted Principal Component Anal-
ysis and Orthogonal Varimax Rotation with Kaiser Nor-
malization. Internal consistency of the German question-
naire was estimated using Cronbach’s alpha [47]. Statisti-
cal analysis was performed with IBMr SPSSr software
Version 22.
Results
Sociodemographic characteristics of study
sample
The final sample comprised the data sets of participants
with given informed consent (n = 172). We included
patients with following conditions: Cystic Fibrosis
(n = 24), Type 1 Diabetes Mellitus (n = 76), Juvenile Idio-
pathic Arthritis (n = 49), Chronic Renal Diseases (n = 12)
and various rare conditions such as Turner syndrome
or Glycogen Storage Disease (n = 11). Mean age of our
population was 16.9 years (SD ±1.8) ranging from 14 to 23
with almost two thirds female respondents (60.5%). More
thanhalf of our respondents (62.2%) reported that German
language was their first or main language, all participants
however were fluent in German. Information on insurance
status was not included in our survey since general social
insurance applies to all our patients. Data on educational
level and school type were either lacking (26.7%), inaccu-
rate (6.4%) or grouped as middle school level (8.7%), as
vocational training (7.6%) or as high school level (50.6%).
Sociodemographic characteristics are listed in Table 1.
Feasibility
Feasibility was tested by assessing if whether or not
respondents could answer the questionnairewithout help,
and whether or not the questionnaire was completed
within 10 min or if participants needed extra explanation
in addition to a brief introduction. The majority (76.7%)
completed the TRAQ-GV-15 within 5 min, about 20%
within 10 min, respectively. Only 24 respondents (13.9%)
Table 1: Sociodemographic characteristics of the study sample
included in the validation of the German version of the Transition

















Eastern Europe 28 16.3%
Western Europe 3 1.7%
Asia 10 5.8%
No data 24 14.0%
Type of education
Middle school 15 8.7%
Vocational training 13 7.6%
Highschool 87 50.6%
Not specified 11 6.4%
No data 46 26.7%
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needed help more than once. It became apparent that
15 min of explanation and introduction were sufficient for
most participants (78.5%). Data shown in Table 2.
Exploratory factor analysis
EFA was conducted on our sample of 172 respondents
to assess a factor structure of the TRAQ-GV-15. Model
adequacy was verified with Kaiser-Meyer-Olkin (0.823)
and Bartlett’s-Test (p < 0.001), indicating suitability for
factor analysis. In the first round of EFA (data not shown)
using Orthogonal Varimax Rotation, four factors demon-
strated an Eigenvalue ≥1 explaining 54.94% of the total
variance. The scree plot showed a clear elbow with only
the first factor, demonstrating an Eigenvalue of 4.38. Fur-
thermore, factor 4 comprised only two items. Analysis of
reliability is not meaningful with solely two items [47].
Therefore, we conducted another round of EFA extracting
three factors accounting for 47.87% of the total variance.
The new factor structure led to three clinically meaningful
domains for the TRAQ-GV-15: domain 1 “Autonomy” (items
01, 04, 05, 07, 12, 13, 15), domain 2 “Health Literacy” (items
02, 09, 10, 11) and domain 3 “Adherence” (items 03, 06,
08, 14,). All items loaded on at least one factor at a level
of more than 0.40 except item15 (“Do you answer ques-
tions that are asked by the doctor, nurse or clinic staff”,
factor loading 0.388). Factor loadings are demonstrated in
Table 3.
Internal consistency
We calculated Cronbach’s alpha Coefficient for inter-
nal consistency. The TRAQ-GV-15 presented globally
a Cronbach’s alpha = 0.824 which indicates a good
Table 2: Feasibility of the administration of the TRAQ-GV-15.
Aspects assessed n = 172 %
Help needed
0–1 times 148 86.1%
2–3 times 20 11.6%
4+ times 4 2.3%
Time for completion
2–5 min 132 76.7%
6–10 min 34 19.8%
10–20 min 5 2.9%
More than 20 min 1 0.6%
Time for counselling
None 6 3.5%
Up to 15 min 135 78.5%
Up to 30 min 28 16.2%
Up to 60 min 2 1.2%
More than 60 min 1 0.6%
TRAQ-GV-15, Transition Readiness Assessment Questionnaire,
German version, 15 items.
Table 3: Cronbach’s alpha and factor loadings of the TRAQ-GV-15







n 166 170 169

















TRAQ-GV-15, Transition Readiness Assessment Questionnaire,
German version, 15 items.
reliability [47]. For the three subscale domains, the values
of Cronbach’s alpha appeared as follows: Domain 1 Cron-
bach’s alpha = 0.779, Domain 2 Cronbach’s alpha = 0.721
and Domain 3 Cronbach’s alpha = 0.507. Results are
presented in Table 3.
TRAQ-GV item values and overall score
In line with the original TRAQ, the items of the TRAQ-GV-
15 score in a range from 1 to 5. Of the expected 2580 (172
responses to 15 Items) values only 12 values were missing
which corresponds to 0.47%missing values.We calculated
the TRAQ-GV-15 mean overall item score (54.77 ± 10.17)
(Table 4). Similarly, we analyzed the 15 items individually,
see Table 5. Item11 (“Do youmanage your money and bud-
get household expenses– for example: use checking/debit
card?”) demonstrated the lowest mean score (2.28 ± 1.50)
whereas item03 (“Do you take medications correctly and
Table 4: TRAQ-GV-15 overall mean score for age groups and sex.
Mean SD








*p-value of < 0.01.
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Table 5: Descriptive statistics of the 15 TRAQ-GV items.
Item n msc SD min max median
Item01 170 3.22 1.45 1 5 4
Item02 171 3.63 1.50 1 5 4
Item03 170 4.75 0.56 2 5 5
Item04 171 3.61 1.42 1 5 4
Item05 169 3.52 1.36 1 5 4
Item06 171 3.85 1.33 1 5 4
Item07 171 3.90 1.35 1 5 4
Item08 172 3.95 1.32 1 5 4
Item09 171 2.32 2.09 1 5 2
Item10 172 2.36 1.52 1 5 2
Item11 172 2.28 1.50 1 5 2
Item12 172 4.53 0.93 1 5 5
Item13 172 3.94 1.36 1 5 4
Item14 172 4.35 1.02 1 5 5
Item15 172 4.66 0.62 1 5 5
msc, mean scores; SD, standard deviation; min, minimum; max,
maximum.
on your own?”) demonstrated the highest mean score
(4.75 ± 0.56).
The data followed a normal distribution, no skew was
found. The two-way (2 × 3) ANOVA showed no signifi-
cant difference for sex. However, age had a significant
(p < 0.001 after Bonferroni adjustment for multiple com-
parisons) effect on the overall TRAQ score. Adolescents
of the youngest age group (14–15.99 years) scored signifi-
cantly lower than YSHCN of the two other age groups com-
prising adolescents and young adults from 16.00 to 17.99
and 18.00–23.99 years. TRAQ overall mean scores were
48.52 vs. 55.86 and 60.27, respectively (Table 4).
Discussion
This work followed the urgent need [5, 10, 25] of improving
the preparation for transfer of YSHCN to the adult med-
ical care. Objective of the study was to translate and to
adapt the English TRAQ 5.0 [38] for use in German speak-
ing countries. Thus, the process of adaptation resulted in
the TRAQ-GV-15.
For cross-cultural adaptation and pilot-testing of the
TRAQ-GV-15, we collected data from 172 YSHCN at two aca-
demic pediatric clinics in Austria and Germany, respec-
tively. Administration proved to be easy and feasible. Most
of our respondents finished the survey in less than 10 min.
The low number of missing values may be the result of
face-to-face intervention including the offer of support
whenever needed. We also collected data on parental edu-
cation, family status of the parents and family income.
Unfortunately, this data were incomplete or contradictory.
Therefore, we could not include them into our analysis.
EFA resulted in 3 subscales. In our opinion, the newly
defined 3 subscales (Domain 1: “Autonomy”, Domain
2: “Health Literacy” and Domain 3 “Adherence”) reflect
domains contributing to transition readiness [37, 38].
Our TRAQ-GV-15 differs from the TRAQ 5.0 in some
aspect. First, the TRAQ 5.0 study was a re-evaluation of
the 29-item TRAQ whereas our study was the first adap-
tation in German language of the TRAQ 5.0 and a pilot-
study of the TRAQ-GV-15. Next, the TRAQ 5.0 includes 20
items,while the TRAQ-GV-15 comprises 15 items.Moreover,
the English TRAQ has a 5-subscale structure, as opposed
to the 3-subscale structure of the German version. Con-
cerning psychometric properties, internal consistency of
the TRAQ-GV-15 was lower for both the overall score (0.94
vs. 0.82) and for the subscales compared to the original
TRAQ5.0. Subscale 1 and subscale 2 of the TRAQ-GV-15 sub-
scales indicated an acceptable internal consistency (0.78
and 0.72) whereas the third subscale demonstrated poor
internal consistency with a Cronbach’s alpha coefficient
under 6.0. Finally, comparing criterion validity, we did not
find significant effects of sex on the TRAQ-GV-15 mean
scores after adjusting for age. This contradicts findings in
earlier TRAQ studies [37, 38, 41]. In linewith previous stud-
ies [35, 37, 38, 41], higher age increased TRAQ-GV-15 scores
in our sample.
This finding underpins that transition readiness
improves with age [38]. Nevertheless, individual matu-
ration follows an unequal pace and needs positive rein-
forcement especially in YSHCN as health risk behaviors
are known to be linked to chronic conditions [49]. Thus,
assessing transition readiness in YSHCN could provide a
good basis to discriminate between YSHCN ready for tran-
sition and AYA in need of intensified attention. Literature
indicates that attitudes such as compliance and adherence
are strongly linked to individual support [50].
Consequently, clinical value of our study results from
raising awareness for the process of HCT in providers,
patients, and parents. Furthermore, the TRAQ-GV-15 could
be used to identify target areas for patient education and
to enhance self-reliance in managing the disease. The
repeated use of the TRAQ-GV-15 could help to evaluate
the individual transition readiness process of adolescent
patients.
Future studies will have to further evaluate the psy-
chometric properties of the TRAQ-GV-15 among larger
study samples. We realize that subscale three needs addi-
tional study. Of utmost interest is the predictive valid-
ity of the TRAQ-GV-15, which will have to be assessed in
follow-up and longitudinal studies measuring transition
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outcome. Eventually, upcoming studies will give clear evi-
dence of what scores to expect from youth differing in
age, sex and condition. Longitudinal data might widen
our understanding of the development of transition readi-
ness and could eventually lead to the establishment of cut-
off scores, helping to identify patient samples at risk for
potentially failed HCT timely [1]. The effect of intervention
programs on TRAQ scores might also be worth investigat-
ing. Goal setting embedded within tailored interventions
is another way to evaluate or improve TRAQ outcomes.
Limitations
The TRAQ-GV-15 is a self-reporting questionnaire which
always holds the risk of socially-desirable answers. More-
over, the possibility of underestimation or rather overesti-
mation of one’s own competencies and skills is a frequent
phenomenon. External observation like expert-rating or
caregiver’s assessment can compensate for these limita-
tions. However, we did not include an external validation
in our study design because we aimed at cross-cultural
adaptation and validation of the TRAQ-GV structure.
Non-response was primarily caused by the fact that
parents did not give informed consent. Therefore, we
could not include data collected from YSHCN (n = 20)
who managed their hospital appointments without par-
ents or otherwise caregivers. Consequently, we had to
excludeAYAwhowere ready tomeet their doctor’s on their
own before the age of 18. This might attribute to a bias in
our data.
Conclusions
We believe that our German version of the TRAQ has a
direct benefit for YSHCN. In our experience, the TRAQ-
GV-15’s administration inevitably led to transition cen-
tered communication with health professionals, encour-
aged caregivers to enhance AYA’s autonomy and sensi-
tized YSHCN for transition specific issues. Based on the
results of our study, we are convinced of the viability of
the implementation into daily hospital routine.
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